Overview

Desvenlafaxine Monotherapy in Dysthymia

Status:
Completed

Trial end date:
2014-06-01

Target enrollment:

Participant gender:

Summary

This multi-centred study will be conducted at two centres. The design will be an open label, flexible-dose study. This investigation will evaluate the efficacy of Desvenlafaxine monotherapy for patients who meet diagnostic criteria for dysthymia.

Phase:

N/A

Details

Lead Sponsor:

Centre for Addiction and Mental Health

Treatments:

Desvenlafaxine Succinate